Market Access Partner Content The 2nd Cell & Gene Therapy Regulatory Affairs Summit Return... Navigate FDA changes & global alignment at the only CGT regulatory strategy summit.
R&D Partner Content 2nd Innovation in Obesity Therapeutics Summit Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly, and Boehringer Ingelheim, as well as innovative biotechs
Partner Content Partner Content MASH Drug Development Summit Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
Partner Content Partner Content 2nd World Companion Diagnostics & Liquid Biopsy Summit APAC The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies
Partner Content Partner Content 10th CAR-TCR Summit – A Decade of Engineering a Disease-Free... It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are transforming the landscape...
Partner Content Partner Content LEAN Cell & Gene Summit Boston Manufacturing Advanced Therapies Just in Time for All Patients
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.